Kentucky Pharmacy and Therapeutics Committee meeting minutes · PDF file Testosterone...

Click here to load reader

  • date post

    24-Aug-2020
  • Category

    Documents

  • view

    2
  • download

    0

Embed Size (px)

Transcript of Kentucky Pharmacy and Therapeutics Committee meeting minutes · PDF file Testosterone...

  • Anthem BlueCross BlueShield Medicaid Kentucky Pharmacy and Therapeutics Committee meeting minutes

    January 2016 Page 1 of 23

    Kentucky Pharmacy and Therapeutics Committee meeting minutes

    December 16, 2015, 1 p.m. Attendees: Andrew Rudd, PharmD Robert Dinwiddie, PharmD Peter Thurman, MD

    Ivy Sams, RN, BSN, CCM Setifah Jordan, PharmD Stephen Broudy, PharmD

    David Crowley

    1. Phosphate binders Review date 3Q15 Clinical review: Phosphate binders Reason for review: Category review PRODUCTS INCLUDED IN THE REVIEW: Renagel (sevelamer HCL tablets), Renvela (sevelamer carbonate), Fosrenol (lanthanum carbonate chewable tablet), Phoslyra (calcium acetate oral solution), Velphoro (sucroferric oxyhydroxide) and Auryxia (ferric citrate) COMPARATOR PRODUCTS: None CURRENT PREFERRED PRODUCTS: Fosrenol, Renagel, Calcium Acetate (generic) and Eliphos RECOMMENDATION:

    • Fosrenol, Renagel will move from preferred to nonpreferred • Velphoro will move from nonpreferred to preferred

    2. Topical immunomodulators

    Review date 3Q15 Clinical review: Topical immunomodulators Reason for review: Category review PRODUCTS INCLUDED IN THE REVIEW: Elidel (pimecrolimus cream) COMPARATOR PRODUCTS: generic Protopic and topical corticosteroids for atopic dermatitis CURRENT PREFERRED PRODUCTS: Elidel cream, Tacrolimus ointment RECOMMENDATION:

    • Elidel will move from preferred to nonpreferred

    3. Short-acting beta agonist (SABAs)

    Review date 3Q15 Clinical review: Short-Acting Beta Agonist (SABAs) Reason for review: Category review PRODUCTS INCLUDED IN REVIEW: ProAir Respiclick dry powder inhaler (albuterol); ProAir HFA inhaler (albuterol), Proventil HFA inhaler (albuterol), Ventolin HFA inhaler (albuterol); Xopenex HFA (levalbuterol) COMPARATOR PRODUCTS: None

  • Anthem BlueCross BlueShield Medicaid Kentucky Pharmacy and Therapeutics Committee meeting minutes

    January 2016 Page 2 of 23

    CURRENT PREFERRED PRODUCTS: Proventil, Ventolin and ProAir RECOMMENDATION:

    • ProAir HFA will move from preferred to nonpreferred • Proventil will move from preferred to nonpreferred

    4. Testosterone replacement

    Review date 3Q15 Clinical review: Testosterone replacement Reason for review: Formulary alignment category PRODUCTS INCLUDED IN REVIEW: Testosterone cypionate injection, Testosterone enanthate injection COMPARATOR PRODUCTS: (BRAND ONLY PRODUCTS) Androderm (testosterone patch); Androgel (testosterone gel); Aveed (testosterone undecanoate injection); Axiron (testosterone solution); Depo-Testosterone (testosterone cypionate) brand only products; First Testosterone (testosterone ointment); First Testosterone MC (testosterone cream); Fortesta (testosterone gel); Natesto (testosterone nasal gel); Striant (testosterone buccal tablet); Testim (testosterone gel); Testopel (testosterone pellet); Testosterone gel (brand only products); Testone CIK Kit (testosterone cypionate); Vogelxo (testosterone gel); METHYLTESTOSTERONE PRODUCTS (BRAND ONLY PRODUCTS) – Android (methyltestosterone capsule); Methitest (methyltestosterone tablet); Testred (methyltestosterone capsule) CURRENT PREFERRED PRODUCTS: Androgel 1% gel pump, Testim 1%, Androderm patch, testosterone 25 mg (1%) gel, testosterone 50 mg (1%) gel RECOMMENDATIONS:

    • Testosterone cypionate injection and testosterone enanthate injection will move from nonpreferred to preferred

    5. Hepatitis C

    Review date 3Q15 Clinical review: Hepatitis C Reason for review: Category review PRODUCT INCLUDED IN REVIEW: Daklinza COMPARATOR PRODUCTS: Sovaldi, Harvoni, Viekira and Olysio CURRENT PREFERRED PRODUCTS: Harvoni and Sovaldi RECOMMENDATIONS:

    • Daklinza will move from nonpreferred to preferred 6. Select cardiovascular agents

    Review date 3Q15 Clinical review: Select cardiovascular agents Reason for review: New drug review PRODUCT INCLUDED IN REVIEW: Entresto

  • Anthem BlueCross BlueShield Medicaid Kentucky Pharmacy and Therapeutics Committee meeting minutes

    January 2016 Page 3 of 23

    COMPARATOR PRODUCTS: None CURRENT PREFERRED PRODUCTS: None RECOMMENDATIONS:

    • Entresto will remain nonpreferred 7. Select cystic fibrosis agents

    Review date 3Q15 Clinical review: Select cystic fibrosis agents Reason for review: New drug review PRODUCT INCLUDED IN REVIEW: Orkambi (ivacaftor/lumacaftor) COMPARATOR PRODUCTS: None CURRENT PREFERRED PRODUCTS: None RECOMMENDATIONS:

    • Orkambi will remain nonpreferred 8. Select antihyperlipidemic agents

    Review date 3Q15 VAC Clinical review: Select antihyperlipidemic agents Reason for review: Category review PRODUCTS INCLUDED IN REVIEW: Praluent and Repatha COMPARATOR PRODUCTS: None CURRENT PREFERRED PRODUCTS: Simvastatin, Pravastatin, Atorvastatin and Lovastatin RECOMMENDATIONS:

    • Praluent and Repatha will remain nonpreferred

    9. Growth hormones

    Review date 3Q15 VAC Clinical review: Growth hormones Reason for review: Category review PRODUCTS INCLUDED IN REVIEW: Humatrope, Norditropin, Omnitrope, Zomacton, Genotropin, Nutropin/AQ and Saizen COMPARATOR PRODUCTS: None CURRENT PREFERRED PRODUCTS: Norditropin and Omnitrope RECOMMENDATIONS:

    • Zomacton will move from nonpreferred to preferred • Nodritropin will move from preferred to nonpreferred • Omnitrope will move from preferred to nonpreferred • Saizen will remain nonpreferred • Genotropin will remain nonpreferred • Nurotpin/AQ will remain nonpreferred • Humatrope will remain nonpreferred

  • Anthem BlueCross BlueShield Medicaid Kentucky Pharmacy and Therapeutics Committee meeting minutes

    January 2016 Page 4 of 23

    10. Select antiemetic agents

    Review date 3Q15 Clinical review: Select antiemetic agents Reason for review: Category review PRODUCTS INCLUDED IN REVIEW: Droperidol vial, Droperidol ampul, Granisteron injection, Ondansetron ODT Ondansetron solution, Ondansetron injection and tablet COMPARATOR PRODUCTS: None CURRENT PREFERRED PRODUCTS: Ondansetron ODT, Ondansetron solution, Ondansetron injection, Ondansetron tablet and Granisetron injection RECOMMENDATIONS:

    • Droperidol vial will move from preferred to nonpreferred • Droperidol ampul will move from preferred to nonpreferred • Granisetron injection will move from preferred to nonpreferred (grandfather current

    utilizers) • Ondansetron solution will move from preferred to nonpreferred (grandfather current

    utilizers) • Ondansetron injection will move from preferred to nonpreferred (grandfather current

    utilizers) • Ondansetron tablet will move from preferred to nonpreferred (grandfather current

    utilizers) 11. Select topical steroids (super potency) agents

    Review date 3Q15 Clinical review: Select topical steroids Reason for review: Focus on super potency topical steroids PRODUCTS INCLUDED IN REVIEW: Clobetasol cream, Clobetasol gel, Clobetasol ointment, Clobetasol solution, Clobetasol Foam, Clobetasol lotion, Clobetasol shampoo, Halobetasol cream, Halobetasol ointment, Betamethasone dipropionate augmented ointment and Diflorasone ointment COMPARATOR PRODUCTS: None CURRENT PREFERRED PRODUCTS: Cormax 0.05% solution, Clobetasol 0.05% gel, Clobetasol 0.05% cream, Clobetasol 0.05% ointment, Clobetasol 0.05% solution, Clobetasol emollient 0.05% cream RECOMMENDATIONS:

    • Halobetasol cream will move to from preferred to nonpreferred • Halobetasol ointment will move from preferred to nonpreferred

    12. Select transmucosal immediate release fentanyl agents

    Review date 3Q15 Clinical review: Select transmucosal immediate release fentanyl agents

  • Anthem BlueCross BlueShield Medicaid Kentucky Pharmacy and Therapeutics Committee meeting minutes

    January 2016 Page 5 of 23

    Reason for review: Category review PRODUCTS INCLUDED IN REVIEW: Fentanyl citrate lozenge, Abstral, Fentora, Lazanda, MSB Actiq, Onsolis and Subsys COMPARATOR PRODUCTS: None CURRENT PREFERRED PRODUCTS: Fentanyl citrate lozenge RECOMMENDATIONS:

    • Fentanyl citrate lozenge will remain preferred

    13. Select electrolyte agents

    Review date 3Q15 Clinical review: Galzin Reason for review: Formulary alignment check PRODUCT INCLUDED IN REVIEW: Galzin COMPARATOR PRODUCTS: None CURRENT PREFERRED PRODUCTS: None (other zinc formulations preferred, none indicated for Wilson’s disease) RECOMMENDATIONS:

    • Galzin will move from nonpreferred to preferred 14. Select gastrointestinal agents

    Review date 3Q15 Clinical review: Select Gastrointestinal Agents Reason for review: Formulary alignment check PRODUCT INCLUDED IN REVIEW: Ipecac syrup COMPARATOR PRODUCTS: None CURRENT PREFERRED PRODUCTS: None RECOMMENDATIONS:

    • Ipecac syrup will move from preferred to nonpreferred 15. Spacer devices

    Review date 3Q15 Clinical review: Spacer devices Reason for review: Category review PRODUCTS INCLUDED IN REVIEW: (PRESCRIPTION) Microchamber, Microspacer for aerosol device, Vortex Holding Chamber, Aerotrach holding chamber, Breatherite MDI spacer, Breathrite valved MDI chamber, Breathrite valved MDI spacer, pocket chamber, Aerochamber Z-stat plus large, Aerochamber Z-stat plus W-flow, Aerochamber Z-stat plus-med, Aerochamber Z-stat plus-small, Ace aerosol cloud enhancer, Aerochamber plus flow-VU, Aerochamber plus W-flowsignal, Primeaire chamber, Riteflo spacer, Liteaire MDI chamber, Prochamber holding